Literature DB >> 33075846

Longitudinal Survey of COVID-19 Burden and Related Policies in U.S. Neonatal Intensive Care Units.

Kaashif A Ahmad1,2,3, Ashley Darcy-Mahoney1,4,5, Amy S Kelleher1, Dan L Ellsbury1, Veeral N Tolia1,6, Reese H Clark1.   

Abstract

OBJECTIVE: This study aimed to determine the prevalence of confirmed novel coronavirus disease 2019 (COVID-19) disease or infants under investigation among a cohort of U.S. neonatal intensive care units (NICUs). Secondarily, to evaluate hospital policies regarding maternal COVID-19 screening and related to those infants born to mothers under investigation or confirmed to have COVID-19. STUDY
DESIGN: Serial cross-sectional surveys of MEDNAX-affiliated NICUs from March 26 to April 3, April 8 to April 19, May 4 to May 22, and July 13 to August 2, 2020. The surveys included questions regarding COVID-19 patient burden and policies regarding infant separation, feeding practices, and universal maternal screening.
RESULTS: Among 386 MEDNAX-affiliated NICUs, responses were received from 153 (42%), 160 (44%), 165 (45%), 148 (38%) across four rounds representing an active patient census of 3,465, 3,486, 3,452, and 3,442 NICU admitted patients on the day of survey completion. Confirmed COVID-19 disease in NICU admitted infants was rare, with the prevalence rising from 0.03 (1 patient) to 0.44% (15 patients) across the four survey rounds, while the prevalence of patients under investigation increased from 0.8 to 2.6%. Hospitals isolating infants from COVID-19-positive mothers fell from 46 to 20% between the second and fourth surveys, while centers permitting direct maternal breastfeeding increased 17 to 47% over the same period. Centers reporting universal severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) screening for all expectant mothers increased from 52 to 69%.
CONCLUSION: Among a large cohort of NICU infants, the prevalence of infants under investigation or with confirmed neonatal COVID-19 disease was low. Policies regarding universal maternal screening for SARS-CoV-2, infant isolation from positive mothers, and direct maternal breastfeeding for infants born to positive mothers are rapidly evolving. As universal maternal screening for SARS-CoV-2 becomes more common, the impact of these policies requires further investigation. KEY POINTS: · In this cohort, neonatal COVID-19 is rare.. · Policies regarding isolation and breastfeeding for infants are rapidly evolving.. · Most hospitals are now providing universal screening for expectant mothers for SARS-CoV-2.. Thieme. All rights reserved.

Entities:  

Year:  2020        PMID: 33075846     DOI: 10.1055/s-0040-1718944

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  5 in total

1.  Conducting Neonatal Intensive Care Unit Research During a Pandemic: Challenges and Lessons Learned.

Authors:  Marliese Dion Nist; Sharon G Casavant; Robin B Dail; Kayla C Everhart; Stephanie Sealschott; Xiaomei S Cong
Journal:  Nurs Res       Date:  2022 Mar-Apr 01       Impact factor: 2.381

2.  In-hospital respiratory viral infections for patients with established BPD in the SARS-CoV-2 era.

Authors:  Matthew J Kielt; Angela Murphy; Jodi Smathers; MaLeah Bates; Leif D Nelin; Edward G Shepherd
Journal:  Pediatr Pulmonol       Date:  2021-10-12

3.  Adaptation of infant mental health services to preterm infants and their families receiving neonatal intensive care unit services during the COVID-19 pandemic.

Authors:  Jessalyn Kelleher; Jack Dempsey; Stephanie Takamatsu; Jennifer J Paul; Evamaria Kent; Allison G Dempsey
Journal:  Infant Ment Health J       Date:  2022-01-08

4.  Feeding practices in public hospitals' neonatal intensive care units: An exploration into the ways in which COVID-19 affected the best practice in Gauteng.

Authors:  Kim A Coutts; Joanne Neille; Nicole Louw
Journal:  S Afr J Commun Disord       Date:  2022-07-22

5.  Variation in United States COVID-19 newborn care practices: results of an online physician survey.

Authors:  Margaret G Parker; Arun Gupta; Helen Healy; Aviel Peaceman; Stephen M Kerr; Timothy C Heeren; Mark L Hudak; Munish Gupta
Journal:  BMC Pediatr       Date:  2022-01-21       Impact factor: 2.125

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.